Market research
4DX.AU 4DMedical Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 4.3667
- Dividend yield
- Not available
- Beta
- 1.95
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU0000095416
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 4.3667
- Dividend yield
- Not available
- Beta
- 1.95
About
About 4DMedical Limited
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 4DX.AU discussion.
5 years, 6 months ago
4DMedical Limited is currently in a long term downtrend where the price is trading 31.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, 4DMedical Limited gets an overall score of 1/5.